Improving the safety of newly approved drugs

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2002年 / 901卷 / 1期
关键词：
Prescription Medication; Drug Withdrawal; Hepatic Toxicity; Accompany Editorial; Drug Labelling;
D O I：
10.2165/00128415-200209010-00005
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3 / 3
相关论文
共 50 条
  • [31] Challenges and opportunities for improving access to approved neonatal drugs and devices
    Lewis, Tamorah
    Wade, Kelly C.
    Davis, Jonathan M.
    [J]. JOURNAL OF PERINATOLOGY, 2022, 42 (06) : 825 - 828
  • [32] Evaluation of Safety Profiles of Blood Cancer Drugs Approved in Japan
    Sachie Kubota
    Kazuyuki Saito
    Shunsuke Ono
    Yasuo Kodama
    [J]. Therapeutic Innovation & Regulatory Science, 2016, 50 : 228 - 235
  • [33] Evaluation of Safety Profiles of Blood Cancer Drugs Approved in Japan
    Kubota, Sachie
    Saito, Kazuyuki
    Ono, Shunsuke
    Kodama, Yasuo
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2016, 50 (02) : 228 - 235
  • [34] Patients' Consent and Drug Safety of Investigational Products and Approved Drugs
    Hirayama, Yoshinobu
    Suzuki-Nishimura, Tamiko
    [J]. YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2011, 131 (06): : 863 - 863
  • [35] Drugs approved for the treatment of multiple sclerosis: review of their safety profile
    Auricchio, Fabiana
    Scavone, Cristina
    Cimmaruta, Daniela
    Di Mauro, Gabriella
    Capuano, Annalisa
    Sportiello, Liberata
    Rafaniello, Concetta
    [J]. EXPERT OPINION ON DRUG SAFETY, 2017, 16 (12) : 1359 - 1371
  • [36] Preclinical research strategies for newly approved drugs as reflected in early publication patterns
    Koster, Ursula
    Nolte, Ingo
    Michel, Martin C.
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2016, 389 (02) : 187 - 199
  • [37] Assessment of Outcomes Associated With the Use of Newly Approved Oncology Drugs in Medicare Beneficiaries
    Green, Angela K.
    Curry, Michael
    Trivedi, Niti
    Bach, Peter B.
    Mailankody, Sham
    [J]. JAMA NETWORK OPEN, 2021, 4 (02)
  • [38] Preclinical research strategies for newly approved drugs as reflected in early publication patterns
    Ursula Köster
    Ingo Nolte
    Martin C. Michel
    [J]. Naunyn-Schmiedeberg's Archives of Pharmacology, 2016, 389 : 187 - 199
  • [39] Newly Approved and Investigational Drugs for Motor Symptom Control in Parkinson's Disease
    Di Luca, Daniel Garbin
    Reyes, Nikolai Gil D.
    Fox, Susan H.
    [J]. DRUGS, 2022, 82 (10) : 1027 - 1053
  • [40] Newly Approved and Investigational Drugs for Motor Symptom Control in Parkinson's Disease
    Daniel Garbin Di Luca
    Nikolai Gil D. Reyes
    Susan H. Fox
    [J]. Drugs, 2022, 82 : 1027 - 1053
12345